Advertisement

‘He’s just in constant pain’: Sooke mom’s desperate plea for son’s drug coverage

The drug that could treat Landen's rare disease costs about $228,000 per year.
The drug that could treat Landen's rare disease costs about $228,000 per year. GoFundMe

A Sooke mother is pleading with the province to fund a drug treatment for her son’s rare disease.

Six-year-old Landen has Systemic Juvenile Idiopathic Arthritis (JIA), an illness his mother Jillian Lanthier says leaves him in chronic pain and sometimes using a walker.

The disease can also prove to be fatal.

LISTEN: Sooke mom pleads for Horgan to hear her

Speaking on CKNW’s The Jill Bennett Show, Lanthier said they’ve unsuccessfully tried two of the three treatment options doctors say exist.
Story continues below advertisement

The third, a drug called Canakinumab, costs more than $225,000 per year — and Landen has been denied PharmaCare coverage.

That prompted Lanthier to write an open letter to Premier John Horgan and Health Minister Adrian Dix to plead for help.

“I have never in my life written any sort of letter like this, but I am reaching a new level of desperation.

I simply don’t have $19,000 per month for medication, but please tell me; what Canadian does?

I also, never imagined in Canada I would be fighting for a drug this expensive,” reads the letter, in part.

“I just wrote to [them] to basically beg for approval to help my son’s quality of life and to be able to survive this disease,” she said.

Lanthier said systemic JIA has transformed her son from a competitive BMX rider to someone who can’t even attend a full day of school.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

He’s also on a steady dose of steroids and painkillers, she said.

“He’s just in constant pain.”

WATCH: Ailing UBC student now approved for expensive drug

Click to play video: 'Ailing UBC student now approved for expensive drug'
Ailing UBC student now approved for expensive drug

Canakinumab is approved by Health Canada, and Lanthier said while it is not covered in any western provinces, it’s under review in some Atlantic jurisdictions.

Story continues below advertisement

She estimated fewer than 10 children in B.C. would need it.

READ MORE: It costs $750K per year to treat her rare disease, and B.C. doesn’t cover the cost

Lanthier acknowledged that while she believes the drug would improve Landen’s life, he may need to take it for years — or even a lifetime.

“Children with systemic JIA are pretty much robbed of their childhood,” she said.

“We have to try. So if it doesn’t work… I wouldn’t know what our options are. But we have to try.”

WATCH: Calls for government funding of cystic fibrosis drug

Click to play video: 'Calls for government funding of cystic fibrosis drug'
Calls for government funding of cystic fibrosis drug

In a statement, the Ministry of Health said it is looking into Landen’s case.

Story continues below advertisement

“Arthritis is a complicated disease with many faces, with over 100 types, including juvenile idiopathic arthritis,” it said.

“The Ministry of Health has just been made aware of this case and will be reaching out to the family to look into the case further.”

Lanthier, meanwhile has started a petition and crowdfunding campaign — though she said the latter’s purpose is more a matter of raising awareness about Landen’s situation.

“I’m a single mom of four and asking for help is very difficult. So I did just yesterday create a GoFundMe page just because I had people asking and I didn’t know what to say.”

She said if the drug is funded by the province, any money raised would be donated to the hospital that’s been treating her son.

Sponsored content

AdChoices